| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-14 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.23 | 4e-13 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.22 | 8e-12 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-10 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-10 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-10 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-10 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-10 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-10 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.25 | 7e-10 |